Canada allows Musk's company to test brain chips – Science and IT

The study is aimed at evaluating the safety and initial functionality of the implant.

Neuralink, owned by billionaire Elon Musk, has received approval to begin clinical trials in Canada of a device designed to enable paralyzed people to use digital devices with just their thoughts.

This is reported by Reuters.

The brain chip startup said the Canadian study aims to evaluate the safety and initial functionality of an implant that allows people with tetraplegia (paralysis of all four limbs) to control external devices with their minds.

Canada's University Health Network Hospital announced in a separate statement that its Toronto facility had been selected to perform this complex neurosurgical procedure.

Health Canada's regulatory body has yet to respond to…